Oncotarget published "Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology" which reported that the authors comprehensively investigated miRNA-193a-3p's mode of action in a panel of human cancer cell lines, with a variety of genetic backgrounds, using 1B3, a synthetic microRNA mimic
SAN FRANCISCO, May 27, 2021 /PRNewswire/ The global oncology information systems market size is expected to reach USD 4.7 billion by 2028, according to a new report by Grand View Research
(0)
SAN FRANCISCO, CA / ACCESSWIRE / May 12, 2021 /
Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the Company ) has submitted its initial application to the NASDAQ to begin the process of moving the listing from the Pink Sheets to the Capital Markets Tier of the NASDAQ Exchange. The Company, its Board, advisors and management team are going to devote resources to accomplish this as swiftly as possible. We are delighted to have submitted the initial application and will work through the process utilizing all resources to our disposal.
ABOUT ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. (OTC PINK:ONPH) (the Company ) is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
Scientists Predict Rise In Deaths From Pancreatic Cancer And Young-Onset Colorectal Cancer forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.